Juvenile myelomonocytic leukemia radiation therapy

Juvenile myelomonocytic leukemia Microchapters
Home
Patient Info
Overview
Historical Perspective
Classification
Pathophysiology
Epidemiology & Demographics
Risk Factors
Screening
Causes of Juvenile myelomonocytic leukemia
Differentiating Juvenile myelomonocytic leukemia from other Diseases
Natural History, Complications & Prognosis
Diagnosis
History & Symptoms
Physical Examination
Lab Tests
Electrocardiogram
Chest X Ray
MRI
CT
Echocardiography or Ultrasound
Other Diagnostic Studies
Treatment
Medical Therapy
Surgical Therapy
Radiation Therapy
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Juvenile myelomonocytic leukemia radiation therapy On the Web
Most recent articles
cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Juvenile myelomonocytic leukemia radiation therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Juvenile myelomonocytic leukemia radiation therapy
CDC on Juvenile myelomonocytic leukemia radiation therapy
Juvenile myelomonocytic leukemia radiation therapy in the news
Blogs on Juvenile myelomonocytic leukemia radiation therapy
to Hospitals Treating Juvenile myelomonocytic leukemia
Risk calculators and risk factors for Juvenile myelomonocytic leukemia radiation therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Radiation/Radiotherapy

Radiation to the spleen does not generally result in a decrease in spleen size or reduction of platelet transfusion requirement.

References

Template:WikiDoc Sources